Dr Andrew Srisuwananukorn on the Potential for AI in Differentiating prePMF and ET

Andrew Srisuwananukorn, MD, of the Ohio State University Comprehensive Cancer Center, explained the potential of artificial intelligence (AI)-based support tools for differentiating primary myelofibrosis (prePMF) and essential thrombocythemia (ET) in the community setting.

Related Keywords

United States ,American ,Andrew Srisuwananukorn ,Ohio State University Comprehensive Cancer Center ,American Society Of Hematology Annual Meeting ,Hematology Annual Meeting ,Myelofibrosis ,Primary Myelofibrosis ,Essential Thrombocythemia ,D ,